Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Young Patient”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05478512
What this trial is testing

Front-line VenObi Combination Followed by Ven or VenZan Combination in Patients With Residual Disease: a MRD Tailored Treatment for Young Patients With High-risk CLL

Who this might be right for
High Risk CLLChronic Lymphocytic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 78
Testing effectiveness (Phase 2)Study completedNCT01643408
What this trial is testing

Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma
Jazz Pharmaceuticals 30
Not applicableStudy completedNCT03204916
What this trial is testing

Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Children's Oncology Group 301
Early research (Phase 1)Study completedNCT00053937
What this trial is testing

Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis Type 1Precancerous Condition
National Cancer Institute (NCI)
Not applicableUnknownNCT00514345
What this trial is testing

CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide

Who this might be right for
Chemotherapeutic Agent ToxicitySarcomaUnspecified Childhood Solid Tumor, Protocol Specific
Children's Cancer and Leukaemia Group 300
Large-scale testing (Phase 3)Study completedNCT00746616
What this trial is testing

Durom(R) Hip Resurfacing System Multicenter Trial

Who this might be right for
Advanced Hip Disease
Zimmer Biomet 40
Not applicableLooking for participantsNCT04173416
What this trial is testing

The Youth Opioid Recovery Support (YORS) Intervention

Who this might be right for
Opioid-use DisorderMedication Adherence
Potomac Health Foundations 150
Testing effectiveness (Phase 2)Study completedNCT00311584
What this trial is testing

Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Oncology Group 59
Testing effectiveness (Phase 2)Study completedNCT00413634
What this trial is testing

The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET)

Who this might be right for
Essential Thrombocythaemia
Shire 24
Not applicableNot Yet RecruitingNCT07128667
What this trial is testing

Clinical Features and Long-Term Prognosis in Young Patients With Acute Myocardial Infarction

Who this might be right for
ACS (Acute Coronary Syndrome)Young Adults
China-Japan Friendship Hospital 200
Large-scale testing (Phase 3)Study completedNCT00294593
What this trial is testing

Efficacy Study of Folinic Acid to Improve Mental Development of Children With Down Syndrome

Who this might be right for
Down Syndrome
Institut Jerome Lejeune 120
Not applicableStudy completedNCT02009826
What this trial is testing

Psychosis-Associated Neuroinflammation in Schizophrenia

Who this might be right for
SchizophreniaPsychosis
Universiteit Antwerpen 106
Large-scale testing (Phase 3)Study completedNCT00499616
What this trial is testing

Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Oncology Group 464
Not applicableNot Yet RecruitingNCT07289815
What this trial is testing

Construction and Application of an Intelligent Collaborative Cardiac Rehabilitation App for Middle-aged and Young Patients With Myocardial Infarction

Who this might be right for
Myocardial InfarctionCardiac RehabilitationAPP
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 232
Not applicableStudy completedNCT00458887
What this trial is testing

Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin

Who this might be right for
OtotoxicityUnspecified Childhood Solid Tumor, Protocol Specific
Children's Oncology Group 301
Testing effectiveness (Phase 2)Ended earlyNCT02541604
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Pediatric and Young Adult Participants With Solid Tumors

Who this might be right for
Solid Tumor
Hoffmann-La Roche 87
Not applicableStudy completedNCT03640325
What this trial is testing

The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

Who this might be right for
CancerBone Marrow NeoplasmsAnxiety+5 more
Seattle Children's Hospital 143
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07748455
What this trial is testing

HMA-Venetoclax Induction in Newly Diagnosed AML

Who this might be right for
AMLAML (Acute Myeloid Leukemia)
Pakistan Blood and Marrow Transplant (PBMT) Group 60
Not applicableUnknownNCT03012464
What this trial is testing

Pathologic Assessment of Rectal Prolapse in the Young

Who this might be right for
Rectal Prolapse
Mansoura University 10
Not applicableUnknownNCT04049149
What this trial is testing

Precision Medicine in Chinese Patients With Young Onset Diabetes

Who this might be right for
Type 2 Diabetes
Chinese University of Hong Kong 884
Next Page